Mike Druckman

ID: 1b837770-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

Drug Compounding Bill to Clarify FDA’s Role, Introduce New Regulatory Limits

Focus on Regulation · November 18, 2013

Compromise Legislative Proposal on Regulation of Compounding Pharmacies Released

Focus on Regulation · September 26, 2013

President signs The Food and Drug Administration Safety and Innovation Act: Summary of certain key provisions

Biosimilars Law Blog · July 12, 2012